Argentina has accepted the coronavirus vaccine developed by Oxford University and the pharmaceutical firm AstraZeneca, making it the second nation after Britain to take action.
The nation’s drug regulator Anmat mentioned on Wednesday it granted an emergency registration restricted to 1 12 months for the sale of the vaccine.
The risk-benefit ratio of the product was acceptable, it mentioned.
Britain had additionally granted emergency approval to the vaccine made by the British-Swedish pharmaceutical firm AstraZeneca and Oxford University.
The drug had proven decrease efficacy in trials than BioNtech/Pfizer vaccine already accepted in some nations, together with Argentina. However, it may be saved with far much less effort and is less expensive.
On Tuesday, Argentina had began to manage the Russia-developed Sputnik V vaccine.
According to official figures, Argentina, which has a inhabitants of round 45 million, has recorded round 1.6 million coronavirus infections and 43,000 deaths.
Later, El Salvador’s Central American drug authority, DNM, mentioned it had granted emergency approval for importation, distribution and use of the vaccine.
For each Latin American nations, it was initially unclear when the drug was anticipated for use and what number of doses every would obtain.
Mexico’s Foreign Minister Marcelo Ebrard acknowledged that approval was imminent within the nation.
In August, the governments of Argentina and Mexico had agreed with AstraZeneca that the vaccine could be manufactured for all of Latin America besides Brazil if accepted within the two nations.
Send your information tales to
and options to
. Chat with us through WhatsApp on +233 55 2699 625.